Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Sucrose ester-C20 to C28 alcohol formulations|
|Abstract:||A stable, efficacious therapeutic cream wherein a principal therapeutic compounds are one or more C-20 to C-28 long chain aliphatic alcohols, of which n-docosanol is exemplary, comprising sucrose cocoate, sucrose stearates or sucrose distearate, or mixtures thereof, is disclosed.|
|Inventor(s):||Katz; David H. (La Jolla, CA), Khalil; Mohammed H. (San Diego, CA), Marcelletti; John F. (San Diego, CA), Pope; Laura E. (Carlsbad, CA), Katz; Lee R. (La Jolla, CA)|
|Assignee:||Lidak Pharmaceuticals (La Jolla, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Formulation; Compound; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.